Home/Filings/4/0000899243-21-041472
4//SEC Filing

Royston Aaron 4

Accession 0000899243-21-041472

CIK 0001851194other

Filed

Oct 24, 8:00 PM ET

Accepted

Oct 25, 6:42 PM ET

Size

13.5 KB

Accession

0000899243-21-041472

Insider Transaction Report

Form 4
Period: 2021-10-25
Royston Aaron
Director10% Owner
Transactions
  • Conversion

    Series B Preferred Stock

    2021-10-25395,0270 total(indirect: See footnote)
    Common Stock (395,027 underlying)
  • Conversion

    Common Stock

    2021-10-25+3,684,7693,684,769 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock

    2021-10-253,289,7420 total(indirect: See footnote)
    Common Stock (3,289,742 underlying)
  • Purchase

    Common Stock

    2021-10-25$16.00/sh+312,500$5,000,0003,997,269 total(indirect: See footnote)
Holdings
  • Common Stock

    (indirect: See footnote)
    1,014,267
Footnotes (3)
  • [F1]All shares of the preferred stock, par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
  • [F2]Shares held by venBio III. venBio GP is the sole general partner of venBio III. venBio Ltd is the sole general partner of venBio GP. The Reporting Person, Robert Adelman and Corey Goodman are each a director of venBio Ltd and may be deemed to share voting and dispositive power over the shares held by venBio III. The Reporting Person disclaims beneficial ownership over the shares held by venBio III except to the extent of his pecuniary interest therein.
  • [F3]Shares held by venBio SPV III, LLC ("venBio SPV"). venBio SPV is wholly owned and managed by venBio Global Strategic Fund III, L.P. ("venBio III"). venBio Global Strategic GP III, L.P., a Cayman Islands partnership ("venBio GP") is the sole general partner of venBio III. venBio Global Strategic GP III, Ltd., a Cayman Islands company ("venBio Ltd") is the sole general partner of venBio GP. The Reporting Person, Robert Adelman and Corey Goodman are each a director of venBio Ltd and may be deemed to share voting and dispositive power over the shares held by venBio SPV. The Reporting Person disclaims beneficial ownership over the shares held by venBio SPV except to the extent of his pecuniary interest therein.

Issuer

Ventyx Biosciences, Inc.

CIK 0001851194

Entity typeother

Related Parties

1
  • filerCIK 0001727703

Filing Metadata

Form type
4
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 6:42 PM ET
Size
13.5 KB